Expect pharma EBITDA growth near 40% for FY20: Rajendra Gogri, Aarti Industries
  • WebDesk BTVI
  • May 22 2019

CMD at Aarti Industries, Rajendra V Gogri, says the company expects volume and topline growth to continue in FY20, and also 40% year on year growth in Pharma to continue all through FY20. The company's revenue grew up by 17.6% to Rs 1,211 Cr, and profit by 46% to Rs 124 Cr for the March quarter.